Pacer Advisors
VIR icon

Pacer Advisors’s Vir Biotechnology VIR Stock Holding History

Pacer Advisors’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23K Buy
+2,296
New +$21.8K ﹤0.01% 2229
2024
Q3 		– Sell
-1,028
Closed -$9.15K – 2707
2024
Q2 		$9.15K Sell
1,028
-1,175
-53% -$11.3K ﹤0.01% 3564
2024
Q1 		$22.3K Buy
2,203
+2,044
+1,286% +$20.8K ﹤0.01% 3424
2023
Q4 		$1.6K Sell
159
-39
-20% -$356 ﹤0.01% 3486
2023
Q3 		$1.85K Hold
198
– – ﹤0.01% 2607
2023
Q2 		$4.86K Buy
198
+28
+16% +$703 ﹤0.01% 3446
2023
Q1 		$3.96K Sell
170
-1,099,224
-100% -$28.1M ﹤0.01% 2079
2022
Q4 		$27.8M Buy
1,099,394
+1,099,190
+538,819% +$26.9M 0.14% 117
2022
Q3 		$4K Sell
204
-784,207
-100% -$19.9M ﹤0.01% 2060
2022
Q2 		$20M Buy
784,411
+784,139
+288,286% +$18.3M 0.15% 117
2022
Q1 		$7K Sell
272
-67
-20% -$1.99K ﹤0.01% 2257
2021
Q4 		$14K Buy
339
+157
+86% +$6.15K ﹤0.01% 2173
2021
Q3 		$8K Hold
182
– – ﹤0.01% 1423
2021
Q2 		$9K Sell
182
-1,557
-90% -$70.8K ﹤0.01% 1385
2021
Q1 		$89K Sell
1,739
-2,639
-60% -$142K ﹤0.01% 1308
2020
Q4 		$117K Buy
4,378
+4,206
+2,445% +$137K ﹤0.01% 1342
2020
Q3 		$6K Buy
172
+86
+100% +$3.7K ﹤0.01% 1377
2020
Q2 		$4K Buy
+86
New +$2.89K ﹤0.01% 931

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pacer Advisors's VIR Position: Q2 2026 in Review

Pacer Advisors opened a new position in Vir Biotechnology (VIR) in Q2 2026: 2,296 shares worth $23K. The stake represents ﹤0.01% of the portfolio and ranks #2229 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in VIR as recently as Q2 2024.

Pacer Advisors first reported a position in VIR in Q2 2020 and has held it in 18 quarters since. The position peaked at $27.8M in Q4 2022. 238 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Pacer Advisors held 2,296 shares of Vir Biotechnology worth $23K as of Q2 2026.
  • Vir Biotechnology was a new Pacer Advisors position in Q2 2026.
  • Vir Biotechnology made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #2229 holding.
  • Pacer Advisors first reported a position in Vir Biotechnology in Q2 2020 and has held it in 18 quarters since.
  • Pacer Advisors's Vir Biotechnology position peaked at $27.8M in Q4 2022.
  • 238 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.